Medipacs, L.L.C. teams up with Tucson Embedded Systems, for safety critical software.

Medipacs announced today it has formed a development and equity partnership with Tucson Embedded Systems for undisclosed terms.

Medipacs a Tucson biotech company is developing advanced infusion technology based on it’s new digital pump system. Tucson Embedded System is a Tucson based engineering firm that develops safety critical software.

Medipacs recently unveiled the first Digital PumpTM and is now focusing on it’s first commercial application, a programmable disposable infusion pump. The Medipacs proprietary pump technology known as pulse activated cell systems, (PACS) uses electrically activated polymers in a computer controlled environment that eliminates the need for electric motors and pump mechanisms.

The Medipacs application is for a market of over ONE MILLION INFUSIONS that happen every day in the United States.

Tucson Embedded Systems Inc (TES) is ISO 9001:2000 engineering firm. TES
specializes in safe and robust embedded systems for control and communications applications for the aerospace, transportation, military, scientific, and medical communities.

Tucson Embedded Systems VP of Business Services Dennis Kenman, is excited about the relationship with Medipacs. “The Medipacs technology for a programmable disposable infusion pump has never been done before. We are committed to building the embedded systems and programming software that will deliver a safer and more affordable pump. This equates directly to increased patient safety and lower patient cost.”

Medipacs systems engineer, Sonia Vohnout, sees huge possibilities with TES as a partner. “With TES as an equity partner, they will lower our engineering and development costs and with a staff of over 50 engineers working on the Medipacs control & software design, they will help accelerate us into the marketplace .”


Medipacs Company Contact:

Laurie Hassey lhassey@medipacs.com
Public Relations (520) 382-3264


This news release may contain forward looking information. Actual future results may differ materially from those contemplated. The risks, uncertainties and other factors, both known & unknown, could influence actual results may be substantial & include those described in documents filed with regulatory authorities. No assurances can be given that any of the events anticipated by the forward looking statements will transpire or occur, or if any of them do so, what benefits the company will derive therefrom.